This inventor holds 2 USPTO granted patents. Top assignees: Shenzhen Hepalink Pharmaceutical Co., Ltd., Other. Active years: 2004-2014.
Company Filing History:
1 out of 1 
1 out of 834,453 Years Active: 2004-2014
Title: Eyal Zcharia: Innovator in Heparanase Research
Introduction
Eyal Zcharia is a prominent inventor based in Jerusalem, Israel. He has made significant contributions to the field of biomedical research, particularly in the study of heparanase, an enzyme involved in various physiological and pathological processes. With a total of 2 patents, Zcharia's work has the potential to impact therapeutic drug development.
Latest Patents
Zcharia's latest patents include innovative inventions that focus on heparanase deficiency. The first patent, titled "Heparanase deficient non-human mammals," relates to cells and transgenic non-human mammals that have at least one disrupted heparanase allele. This invention also outlines methods for screening therapeutic drug candidates using these heparanase deficient non-human mammals and cells. The second patent, "Avian and reptile derived polynucleotide encoding a polypeptide having heparanase activity," involves avian and reptile derived heparanase and the nucleic acids that encode it.
Career Highlights
Throughout his career, Zcharia has worked with notable companies, including Shenzhen Hepalink Pharmaceutical Co., Ltd. His research has contributed to advancements in understanding heparanase's role in various diseases, paving the way for new therapeutic approaches.
Collaborations
Zcharia has collaborated with esteemed colleagues in his field, including Israel Vlodavsky and Jin-ping Li. These partnerships have enhanced the depth and breadth of his research, leading to impactful discoveries.
Conclusion
Eyal Zcharia's innovative work in heparanase research exemplifies the importance of scientific inquiry in developing new therapeutic strategies. His contributions continue to influence the biomedical field and hold promise for future advancements.